| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0042-6822(88)90079-7 |
| P698 | PubMed publication ID | 2847416 |
| P2093 | author name string | Ho DY | |
| Mocarski ES | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 279-283 | |
| P577 | publication date | 1988-11-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse | |
| P478 | volume | 167 |
| Q24313102 | A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus |
| Q45755891 | A live non-neurovirulent herpes simplex virus vector expresses beta-galactosidase in the nervous system of the Wistar and Sprague-Dawley strain rat for a prolonged period |
| Q45369844 | A microRNA of infectious laryngotracheitis virus can downregulate and direct cleavage of ICP4 mRNA. |
| Q34341150 | A mutation in the latency-related gene of bovine herpesvirus 1 disrupts the latency reactivation cycle in calves |
| Q39642251 | Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. |
| Q36828870 | Activity of the simian virus 40 early promoter-enhancer in herpes simplex virus type 1 vectors is dependent on its position, the infected cell type, and the presence of Vmw175 |
| Q36256866 | Adenovirus-mediated gene transfer of the tumor suppressor, p53, induces apoptosis in postmitotic neurons |
| Q64256864 | Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets |
| Q43586571 | Alphaherpesvirus latency: its role in disease and survival of the virus in nature |
| Q36256746 | Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene |
| Q35891903 | Analysis of bovine herpesvirus 1 transcripts during a primary infection of trigeminal ganglia of cattle |
| Q48822745 | Axon-mediated gene transfer of retinal ganglion cells in vivo |
| Q26864175 | Bovine Herpes Virus 1 (BHV-1) and Herpes Simplex Virus Type 1 (HSV-1) Promote Survival of Latently Infected Sensory Neurons, in Part by Inhibiting Apoptosis |
| Q44156744 | Comparative efficacy of expression of genes delivered to mouse sensory neurons with herpes virus vectors. |
| Q35796504 | Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain. |
| Q30478992 | Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host |
| Q33422983 | De novo synthesis of VP16 coordinates the exit from HSV latency in vivo |
| Q33873085 | Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption |
| Q39591444 | Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system |
| Q45736046 | Effect of immunity on gene delivery into anterior horn motor neurons by live attenuated herpes simplex virus vector |
| Q45729782 | Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector |
| Q49053762 | Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection |
| Q39550929 | Equine herpesvirus 1 gene 12 can substitute for vmw65 in the growth of herpes simplex virus (HSV) type 1, allowing the generation of optimized cell lines for the propagation of HSV vectors with multiple immediate-early gene defects |
| Q40985230 | Expression of the enhanced green fluorescent protein by herpes simplex virus type 1 (HSV-1) as an in vitro or in vivo marker for virus entry and replication |
| Q34553254 | Failure of thymidine kinase-negative herpes simplex virus to reactivate from latency following efficient establishment |
| Q34179305 | Gene delivery and gene therapy with herpes simplex virus-based vectors |
| Q71628168 | Gene therapy for head and neck cancer |
| Q33837123 | Gene therapy in the CNS. |
| Q34476794 | Gene therapy with herpes simplex virus vectors: progress and prospects for clinical neuroscience |
| Q41089982 | Gene transfer into sympathetic preganglionic neurons in vivo using a non-replicating thymidine kinase-deficient herpes simplex virus type 1. |
| Q36624021 | Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette. |
| Q36832257 | Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding protein |
| Q33995752 | HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications |
| Q39693154 | Herpes simplex virus (HSV) immediate-early (IE) promoter-directed reporter system for the screening of antiherpetics targeting the early stage of HSV infection |
| Q28288318 | Herpes simplex virus as a transneuronal tracer |
| Q34308944 | Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse |
| Q36654762 | Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia |
| Q35044114 | Herpes simplex virus type 1 and bovine herpesvirus 1 latency |
| Q33851697 | Herpes simplex virus type 1 corneal infection results in periocular disease by zosteriform spread |
| Q33912005 | Herpes simplex virus type 2 UL24 gene is a virulence determinant in murine and guinea pig disease models |
| Q40599511 | Herpes simplex virus vectors for gene therapy |
| Q34040013 | Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss |
| Q45175987 | Herpesvirus vector gene transfer and expression of beta-glucuronidase in the central nervous system of MPS VII mice |
| Q40852248 | Herpesviruses: expression of genes in postmitotic brain cells |
| Q36030112 | Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication |
| Q48721265 | Immune effector cell (IEC)-mediated protection from HSV-1 retinitis occurs in the brain |
| Q48489387 | In situ PCR for in vivo detection of foreign genes transferred into rat brain |
| Q35837593 | In vivo deletion analysis of the herpes simplex virus type 1 latency-associated transcript promoter |
| Q43722391 | Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors |
| Q42280576 | Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain |
| Q45742031 | Long-term gene expression in the anterior horn motor neurons after intramuscular inoculation of a live herpes simplex virus vector |
| Q40041772 | Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. |
| Q51498938 | Recent advances in the pharmacology of nerve-injury pain. |
| Q44306210 | Regulated transgene delivery by ganciclovir in the brain without physiological alterations by a live attenuated herpes simplex virus vector |
| Q36793331 | Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses |
| Q48574844 | Spread of HSV-1 to the suprachiasmatic nuclei and retina in T cell depleted BALB/c mice |
| Q36637629 | Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells |
| Q34141635 | Tetracycline-regulated cardiac gene expression in vivo. |
| Q39732720 | The ORF37 (UL24) is a neuropathogenicity determinant of equine herpesvirus 1 (EHV-1) in the mouse encephalitis model |
| Q45764659 | The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1. |
| Q33654414 | Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle |
| Q90026606 | Trans-synaptic Neural Circuit-Tracing with Neurotropic Viruses |
| Q41682404 | Two α-herpesvirus strains are transported differentially in the rodent visual system |
| Q37615161 | Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells). |
| Q35618384 | Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. |
| Q41235446 | Viral vectors for modulating gene expression in neurons |
Search more.